Skip links
Companies
› United States › TONIX PHARMACEUTICALS HOLDING CORP.
TONIX PHARMACEUTICALS HOLDING CORP. logo

TONIX PHARMACEUTICALS HOLDING CORP.

Public Limited Company Active

Registration No.
001500331
Incorporation Date
Not disclosed
Company Type
Public Limited Company
Address
Chatham, United States
Website
www.tonixpharma.com/
Source: New Jersey Division of Revenue & Enterprise Services

TONIX PHARMACEUTICALS HOLDING CORP. is a Public Limited Company registered in United States under 001500331, and its current status with New Jersey Division of Revenue & Enterprise Services is active. Its registered address on file is Chatham, United States. 5 shareholders are on record for TONIX PHARMACEUTICALS HOLDING CORP., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 21 October 2026.

Data Provenance
This record is sourced directly from official government registries, including New Jersey Division of Revenue & Enterprise Services.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Five shareholders are currently on record for TONIX PHARMACEUTICALS HOLDING CORP., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is iShares Trust-iShares Russell 2000 ETF, holding 10.7% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund at 5.7%; the remaining 3 shareholders shown hold smaller stakes.

The register reports 11 shareholders in total, though only the top 5 by holding are shown in this view.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
iShares Trust-iShares Russell 2000 ETF 10.7% New Jersey Division of Revenue & Enterprise Services
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 5.7% New Jersey Division of Revenue & Enterprise Services
Northern Funds-SMALL CAP VALUE FUND 4.5% New Jersey Division of Revenue & Enterprise Services
TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund 4% New Jersey Division of Revenue & Enterprise Services
iShares Trust-iShares Russell 2000 Value ETF 3.9% New Jersey Division of Revenue & Enterprise Services

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Treasurer of TONIX PHARMACEUTICALS HOLDING CORP. currently on record is SETH LEDERMAN; five officers are currently on record for TONIX PHARMACEUTICALS HOLDING CORP., filed with New Jersey Division of Revenue & Enterprise Services.

The register reports 25 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at TONIX PHARMACEUTICALS HOLDING CORP. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

SL
SETH LEDERMAN ACTIVE

Residence
🇺🇸 United States
Occupation
Treasurer

SL
SETH LEDERMAN ACTIVE

Residence
🇺🇸 United States
Occupation
President

BS
BRADLEY SAENGER ACTIVE

Residence
🇺🇸 United States
Occupation
Treasurer

SL
SETH LEDERMAN ACTIVE

Residence
🇺🇸 United States
Occupation
Secretary

GS
GREGORY SULLIVAN ACTIVE

Residence
🇺🇸 United States
Occupation
Secretary

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Group Structure

TONIX PHARMACEUTICALS HOLDING CORP. has no recorded parent company — it sits at the top of its own group structure, with 6 subsidiaries recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 6 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 6 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Ultimate HQ
TONIX PHARMACEUTICALS HOLDING CORP.
United States
Tonix Pharmaceuticals, Inc.+ subsidiaries
United StatesUS NJ 4366460

Krele LLC
United StatesUS NY 4860501

Tonix Medicines, Inc.
United States#0191380197

Jenner Institute, LLC
United StatesUS MT 3789891

Jenner LLC
United StatesUS NY C1174559

Tonix R&D Center, LLC
United StatesUS MD 6183032

Explore the full group structure
Map the complete corporate hierarchy: parent companies, subsidiaries, and cross-border ownership chains.

View full group structure →

Need the full UBO picture on TONIX PHARMACEUTICALS HOLDING CORP.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns TONIX PHARMACEUTICALS HOLDING CORP.?

Five shareholders are currently on record for TONIX PHARMACEUTICALS HOLDING CORP., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is iShares Trust-iShares Russell 2000 ETF, holding 10.7% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund at 5.7%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is TONIX PHARMACEUTICALS HOLDING CORP.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for TONIX PHARMACEUTICALS HOLDING CORP. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does TONIX PHARMACEUTICALS HOLDING CORP. have on record?

5 shareholders are shown on record for TONIX PHARMACEUTICALS HOLDING CORP.. The register reports 11 in total; only the top 5 by holding are shown here.

What is TONIX PHARMACEUTICALS HOLDING CORP.'s company registration number?

TONIX PHARMACEUTICALS HOLDING CORP.'s registration number is 001500331, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.

Is TONIX PHARMACEUTICALS HOLDING CORP. still an active company?

TONIX PHARMACEUTICALS HOLDING CORP.'s status on New Jersey Division of Revenue & Enterprise Services is listed as active.

What is TONIX PHARMACEUTICALS HOLDING CORP.'s registered address?

The registered address on file for TONIX PHARMACEUTICALS HOLDING CORP. is Chatham, United States.

What legal structure is TONIX PHARMACEUTICALS HOLDING CORP. registered as?

TONIX PHARMACEUTICALS HOLDING CORP. is registered as a Public Limited Company in United States.

Who are the officers/directors of TONIX PHARMACEUTICALS HOLDING CORP.?

The Treasurer of TONIX PHARMACEUTICALS HOLDING CORP. currently on record is SETH LEDERMAN; five officers are currently on record for TONIX PHARMACEUTICALS HOLDING CORP., filed with New Jersey Division of Revenue & Enterprise Services. Management authority at TONIX PHARMACEUTICALS HOLDING CORP. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does TONIX PHARMACEUTICALS HOLDING CORP. have a parent company or subsidiaries?

TONIX PHARMACEUTICALS HOLDING CORP. has no recorded parent company — it sits at the top of its own group structure, with 6 subsidiaries recorded beneath it across 1 jurisdiction. Those 6 subsidiaries span United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 6 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.

Can Zavia monitor changes to TONIX PHARMACEUTICALS HOLDING CORP.'s ownership over time?

This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to TONIX PHARMACEUTICALS HOLDING CORP.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access TONIX PHARMACEUTICALS HOLDING CORP.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like TONIX PHARMACEUTICALS HOLDING CORP.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 21 October 2026.

This website uses cookies to improve your web experience.